Lanean...
Proteinase‐activated receptor 1: A target for repurposing in the treatment of COVID‐19?
In the search to rapidly identify effective therapies that will mitigate the morbidity and mortality of COVID‐19, attention has been directed towards the repurposing of existing drugs. Candidates for repurposing include drugs that target COVID‐19 pathobiology, including agents that alter angiotensin...
Gorde:
| Argitaratua izan da: | Br J Pharmacol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361899/ https://ncbi.nlm.nih.gov/pubmed/32639031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.15194 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|